Accuray Incorporated’s ARAY share price has dipped by 8.39%, which has investors questioning if this is right time to buy.

The growth was driven by robust performance across CyberKnife, TomoTherapy (Radixact) and the newly launched Helix systems. The Helix platform secured 12 new orders in emerging markets ...

CIRC: Attained a New High in Fiscal Year 2024 - Continuoued to consolidate The leading position of nuclear medicine and ...

It’s deeply troubling that, over the past few weeks, about two dozen international students at UW-Madison and recent alumni ...

The new generation of Precision radiation therapy planning system was successfully approved for medical device registration certificate, and the world's first spiral tomotherapy system ...

40 However, there are differences in the mode of delivery that make a difference in this respect: some IMRT methods (e.g. tomotherapy) deliver sequential treatment to parts of the target volumes ...

ABSTRACT: Cervical cancer remains a major problem in Madagascar. Its occurrence affects all aspects of an individual’s life. Our study therefore assessed the impact of cervical cancer and its ...